Loading current stock analysis…
Loading current stock analysis…
India
Reported ownership for FY2027-Q2 as of 2026-09-30.
As of 06 Nov 2026, 03:30 pm
SEBI is monitoring governance-related developments at Tata Sons, specifically regarding the reappointment of N Chandrasekaran and the proposed listing of Tata Sons. While SEBI Chairman Tuhin Kanta Pandey confirmed that the group's 26 listed subsidiaries continue to follow all Listing Obligations and Disclosure Requirements (LODR) norms, seven listed Tata entities collectively hold an 11.92% stake in Tata Sons.
The Board of Directors meeting to consider and approve the Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half-year ended September 30, 2026, is scheduled for November 7, 2026. An analysts’/investors’ conference call to discuss these results will be held on the same day at 5:30 p.m. IST, featuring Managing Director & CEO R Mukundan and CFO Nandakumar Tirumalai.
As of November 6, 2026, Tata Chemicals has recorded a return of -30.5% over the past year and -41.6% since the start of the observed period. The stock is currently trading at ₹606.9, with a maximum drawdown of -44.5%. Technical indicators show a bearish daily supertrend direction, and the annualized volatility stands at +33.4%.
As of 06 Nov 2026, 03:30 pm
Showing 3 of 6 candles
Recent drawdown or price variability is materially high and may lead to larger short-term outcomes.
Primary driver: Price remains materially below a previous peak
The session opened materially above the previous close, indicating a sharp repricing at the open.
The move may reflect new information; subsequent price follow-through is worth monitoring.
Trading activity was substantially higher than usual and the price closed higher.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
Latest complete financial results for Q2 FY27 and comparative quarterly trends.
| Metric | Q2 FY26 | Q1 FY27 | Q2 FY27(Latest) |
|---|---|---|---|
| Revenue From Operations | ₹3,877 crore | PEAK₹4,255 crore | ₹4,177 crore |
| Expenses | ₹3,769 crore | ₹4,184 crore | PEAK₹4,298 crore |
| Finance Costs | ₹144 crore | ₹148 crore | PEAK₹151 crore |
| Profit Before Tax | PEAK₹181 crore | ₹127 crore | -₹26 crore |
| Tax Expense | PEAK₹82 crore | ₹50 crore | ₹44 crore |
| Profit Loss For Period | PEAK₹154 crore | ₹60 crore | -₹50 crore |
| Basic Earnings Loss Per Share From Continuing And Discontinued Operations | PEAK₹3.02 per share | -₹0.67 per share | -₹4.79 per share |
Tata Chemicals reported a consolidated loss of ₹50 crore for Q2 FY2026-27, against a profit of ₹154 crore in Q2 FY2025-26 and ₹60 crore in Q1 FY2026-27. Revenue from operations grew 7.7% year on year to ₹4,177 crore, but expenses rose faster, increasing 14.0% to ₹4,298 crore.
Operating cash flow was ₹64 crore. Investing cash flow was ₹1,086 crore, while financing cash flow was an outflow of ₹982 crore. Reported free cash flow was ₹1,150 crore. Cash and cash equivalents stood at ₹556 crore on 30 September 2026, compared with ₹381 crore on 31 March 2026 and ₹371 crore on 30 September 2025.
Year-on-year revenue growth was outweighed by faster expense growth, and Tata Chemicals moved from profit to loss both year on year and sequentially. Cash and cash equivalents rose and total borrowings were lower than at March-end, but operating cash flow was ₹64 crore and current borrowings increased.
Disclosed bulk and block transactions involving Tata Chemicals, shown for the latest 90 days.
Exchange disclosures and regulatory announcements for Tata Chemicals.
Tata Chemicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. |SUBJECT: Outcome of Board Meeting
Outcome of Board Meeting |SUBJECT: Outcome of Board Meeting
Tata Chemicals Limited’s Board approved unaudited consolidated and audited standalone financial results for the quarter and half-year ended September 30, 2026, at its meeting on November 7, 2026. The consolidated limited review report was unmodified, and the standalone auditor’s report gave an unmodified opinion. The results also disclose that subsidiary Tata Chemicals Magadi Limited received a Kenyan ministry notice suspending mining operations and exports pending a compliance review; the Group reported a ₹21 crore loss in the quarter from the suspension. The subsidiary made compliance submissions and initiated proceedings before the Environment and Land Court challenging the suspension and seeking relief.
Tata Chemicals Limited submitted an investor presentation to the NSE and BSE on November 7, 2026, detailing financial results for the quarter and half-year ended September 30, 2026. Consolidated revenue increased to ₹8,432 Cr in H1FY27 from ₹7,596 Cr in H1FY26, driven by higher volumes in India and the US, though consolidated EBITDA declined due to lower realizations in the US, higher input costs, and fixed cost increases. The company reported a consolidated Net Debt of ₹6,127 Cr as of September 2026. Operational highlights include volume growth in Living Essentials (Salt & Bicarb) and Industrial Essentials (Soda Ash), while Farm Essentials faced demand headwinds. Strategic updates confirm the Novabay acquisition effective January 1, 2026, ongoing debottlenecking projects including an 82.5 KTPA IVSD plant at Mithapur and a 50 KTPA Precipitated Silica Plant at Cuddalore, and ESG initiatives such as the 85 TPH Biomass Boiler Project at Mithapur.
Tata Chemicals Limited filed its Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half-year ended September 30, 2026, with the NSE and BSE on November 7, 2026. For Q2 FY27, standalone revenue from operations grew 8% to ₹1,303 Cr and EBITDA rose 22% to ₹292 Cr, while Profit After Tax (PAT) declined 31% to ₹122 Cr. Consolidated results showed an 8% revenue increase to ₹4,177 Cr but a sharp deterioration in profitability, with EBITDA falling to ₹381 Cr from ₹537 Cr and recording a Loss After Tax of ₹50 Cr compared to a profit of ₹219 Cr in the prior year period. The consolidated decline was attributed to lower realizations in overseas subsidiaries (particularly US exports to Southeast Asia), elevated UK natural gas costs, and the temporary suspension of Kenya operations. Net debt stood at ₹6,127 Cr as of September 30, 2026.
Integrated Filing- Financials|Original|
Integrated Filing- Financials|Original|
Tata Chemicals Limited submitted a filing to the BSE and NSE providing the audio recording link for the Analysts/Investors Call held on November 7, 2026. The call discussed the Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half-year ended September 30, 2026. These results were approved by the Board of Directors during a meeting held on the same day.
Recent market and company developments associated with Tata Chemicals.
SEBI Chairman Tuhin Kanta Pandey stated that the regulator is monitoring governance-related developments at the holding company level of the Tata Group amid differences over issues including the reappointment of N Chandrasekaran and the proposed listing of Tata Sons.
SEBI Chairman Tuhin Kanta Pandey stated that the regulator is monitoring governance developments at Tata Sons, specifically regarding the reappointment of N Chandrasekaran and its proposed listing, while confirming that the group's 26 listed subsidiaries continue to follow all Listing Obligations and Disclosure Requirements (LODR) norms.
SEBI Chairman Tuhin Kanta Pandey confirmed that the regulator is monitoring governance developments at Tata Sons amid questions over leadership and a proposed listing, while noting that the group's listed subsidiaries continue to comply with LODR norms. Seven listed Tata entities, including Tata Steel and Tata Motors Passenger Vehicles, collectively hold an 11.92% stake in Tata Sons, which is majority-owned by Tata Trusts.
Tata Chemicals share price opened at ₹578.65 against its previous close of ₹575.50 and jumped 9.7% to hit an intraday high of ₹631.55.
Kenyan President William Ruto had earlier ordered the Indian firm to leave the century-old Magadi soda ash operation it has run for two decades.
Tata Chemicals is examining legal options after Kenya's High Court ruled it lacks jurisdiction over a dispute involving subsidiary Tata Chemicals Magadi Ltd.
Tata Chemicals on Saturday said the High Court of Kenya has ruled that it lacks jurisdiction over a dispute involving its Kenyan subsidiary, Tata Chemicals Magadi Ltd (TCML), and cannot take further steps in the matter.
Tata Chemicals said the High Court of Kenya has ruled that it lacks jurisdiction over a dispute involving its subsidiary, Tata Chemicals Magadi Ltd (TCML), and cannot take further steps in the matter. TCML is examining the October 23 order and will decide on its next legal steps.
Comprehensive Section Breakdown for Tata Chemicals
Strategic Vision: Sustainable chemistry solutions provider with global operations.
• Global operational network across four continents
• Science-driven product development
• Diversified portfolio serving multiple industries
Revenue from operations was ₹4,177 crore, down 1.8% from ₹4,255 crore in Q1 FY2026-27 and up from ₹3,877 crore in Q2 FY2025-26. Total income was ₹4,272 crore, compared with ₹4,311 crore in Q1 FY2026-27 and ₹4,015 crore in Q2 FY2025-26.
Expenses increased to ₹4,298 crore from ₹4,184 crore in Q1 FY2026-27 and ₹3,769 crore in Q2 FY2025-26. The quarter’s expenses included ₹653 crore for materials consumed, ₹567 crore in employee benefits, ₹351 crore in depreciation and ₹151 crore in finance costs. Finance costs were ₹148 crore in Q1 FY2026-27 and ₹144 crore in Q2 FY2025-26.
Profit before tax was a loss of ₹26 crore, compared with profits of ₹127 crore in Q1 FY2026-27 and ₹181 crore in Q2 FY2025-26. After a tax expense of ₹44 crore, the loss from continuing operations was ₹70 crore. A ₹20 crore share of profit from associates and joint ventures brought the consolidated loss for the period to ₹50 crore.
The loss attributable to owners of the parent was ₹122 crore, while ₹72 crore of profit was attributable to non-controlling interests. Basic and diluted loss per share were both ₹4.79, versus a loss of ₹0.67 per share in Q1 FY2026-27 and earnings of ₹3.02 per share in Q2 FY2025-26.
Total comprehensive income was ₹198 crore, including other comprehensive income of ₹248 crore.
Current borrowings were ₹2,696 crore on 30 September 2026, up from ₹2,624 crore on 31 March 2026. Non-current borrowings fell to ₹5,066 crore from ₹5,377 crore over the same period. Total borrowings were ₹7,762 crore, below ₹8,001 crore at the prior financial year-end, while current financial liabilities were ₹5,728 crore.
Inventories increased to ₹3,104 crore from ₹3,082 crore at 31 March 2026, and current trade receivables rose to ₹2,507 crore from ₹2,088 crore. Property, plant and equipment was ₹9,898 crore, while capital work in progress declined to ₹908 crore from ₹1,014 crore.
Category: Manufacturing
These include key ingredients such as soda ash and sodium bicarbonate, which are integral to the production of everyday goods.
Category: Manufacturing
These encompass offerings in nutrition, advanced materials, and other specialized chemicals, including Precipitated Silica, Fructo-oligosaccharides, Cement, Nano Zinc Oxide, and Allied Chemicals.
Key Products & Services: Precipitated Silica • Fructo-oligosaccharides • Cement • Nano Zinc Oxide • Allied Chemicals
Core Thesis: The interplay between basic and specialty chemicals allows Tata Chemicals to cater to foundational chemical demands while also addressing advanced and niche requirements across various sectors.
• Diversified Product Portfolio: The company generates revenue by manufacturing and selling a diversified portfolio of basic and specialty chemistry products. • Global Operational Network: With manufacturing facilities located strategically across its key regions of operation—India, the United Kingdom, the United States, and Kenya—the company maintains a supply chain capable of delivering products to diverse end markets. • Science-Driven Innovation: It focuses on science-driven products and innovation to deliver chemistry solutions.